| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2007 | WO2007000289A1 Nitro-substituted hydroxyindoles,their use as inhibitors of phosphodiesterase 4, and processes for preparing them |
| 01/04/2007 | WO2007000248A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 01/04/2007 | WO2007000246A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 01/04/2007 | WO2007000241A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 01/04/2007 | WO2007000240A1 Isoquinoline derivatives as inhibitors of rho-kinase |
| 01/04/2007 | WO2007000235A1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
| 01/04/2007 | WO2007000234A1 Moxifloxacin therapeutic use for treating immune system functional disturbances |
| 01/04/2007 | WO2007000193A1 Isoflavone nanoparticles and use thereof |
| 01/04/2007 | WO2007000192A1 Topical compositions comprising nanoparticles of an isoflavone |
| 01/04/2007 | WO2007000121A1 A method for the production of the hemi-calcium salt of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 01/04/2007 | WO2007000056A1 Aromatase inhibitors for emergency contraception |
| 01/04/2007 | WO2007000046A1 Methods for diagnosing functional bowel disease |
| 01/04/2007 | WO2007000043A2 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
| 01/04/2007 | WO2007000004A1 Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group |
| 01/04/2007 | WO2007000001A2 Pleuromutilin salts with salicylic acid, azelaic acid, sebacic acid and diclofenac |
| 01/04/2007 | WO2006125194A3 Piperazine derivatives and their uses as therapeutic agents |
| 01/04/2007 | WO2006124996A3 Inhibitors of polo-like kinase-1 |
| 01/04/2007 | WO2006124506A3 Combination and use of drugs |
| 01/04/2007 | WO2006124462A3 Compounds and compositions as protein kinase inhibitors |
| 01/04/2007 | WO2006123113A3 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
| 01/04/2007 | WO2006120696A3 An improved pharmaceutical composition |
| 01/04/2007 | WO2006117660A3 Method for treating cancer, coronary, inflammatory and macular disease, combining the modulation of zinc- and/or copper dependent proteins |
| 01/04/2007 | WO2006114702A3 Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor |
| 01/04/2007 | WO2006113462B1 Formulations of quaternary ammonium neuromuscular blocking agents |
| 01/04/2007 | WO2006110917A3 Spiro-oxindole compounds and their uses as therapeutic agents |
| 01/04/2007 | WO2006110816A3 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 01/04/2007 | WO2006108714A3 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 01/04/2007 | WO2006108127A3 Crystalline form of a quinolinone-carboxamide compound |
| 01/04/2007 | WO2006106521A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 01/04/2007 | WO2006106423A3 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| 01/04/2007 | WO2006106220A3 Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals. |
| 01/04/2007 | WO2006105204A3 Compositions and their uses directed to thymus and activation-regulated chemokine (tarc) |
| 01/04/2007 | WO2006104667A3 Novel method |
| 01/04/2007 | WO2006103677A3 Exogenous markers for oxidative stress |
| 01/04/2007 | WO2006103544A3 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 01/04/2007 | WO2006102102A3 Tgf-beta modulators and methods for using the same |
| 01/04/2007 | WO2006101794A3 Stable tablet dosage forms of proton pump inhibitors |
| 01/04/2007 | WO2006096769A3 Use of alpha-glucosidase inhibitors to treat alphavirus infections |
| 01/04/2007 | WO2006096173A8 Pharmaceutical compositions and methods for peptide treatment |
| 01/04/2007 | WO2006091941A3 Compositions and methods for treating and preventing cardiomyopathy and heart disease |
| 01/04/2007 | WO2006087642A3 9a-carbamoyl and thiocarbamoyl azalides with antimalarial activity |
| 01/04/2007 | WO2006085228A3 9a-carbamoyl-y-aminopropyl and 9a-thiocarbamoyl-y-aminopropyl-azalides with antimalarial activity |
| 01/04/2007 | WO2006075256A3 9a-carbamoyl-ϝ-aminopropyl- and 9a-thiocarbamoyl-ϝ-aminopropyl-azalides with antimalarial activity |
| 01/04/2007 | WO2006073610A3 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 01/04/2007 | WO2006072615A3 Triazolophthalazines as pde2-inhibitors |
| 01/04/2007 | WO2006069182A3 THIENOISOQUINOLINE-PHENYLSULFONAMIDES AND THEIR USE AS ER-NFkB INHIBITORS |
| 01/04/2007 | WO2006068973A3 Methods for use of oral care compositions containing free-b-ring flavonoid anti-oxidants |
| 01/04/2007 | WO2006067614A3 Heteroaromatic derivatives useful as anticancer agents |
| 01/04/2007 | WO2006065894A3 Methods for inhibiting stat3 signaling in immune cells |
| 01/04/2007 | WO2006060765A3 Use of a compound that activates a vitamin d receptor for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 01/04/2007 | WO2006060500A3 Arylpyrazoles and methods of using same for control of insect pests that bore into trees |
| 01/04/2007 | WO2006058298A3 A method of administering anti-angiogenic agents and a method of treating disease using same |
| 01/04/2007 | WO2006058140A3 Capsaicinoid gel formulation and uses thereof |
| 01/04/2007 | WO2006050148A3 Propargyl trifluoromethoxy aminobenzimidazole derivatives |
| 01/04/2007 | WO2006047479A3 C-fms kinase inhibitors |
| 01/04/2007 | WO2006044916A3 Use of na+/ k+-atpase inhibitors and antagonists thereof |
| 01/04/2007 | WO2006041872A3 Thrombin receptor antagonists |
| 01/04/2007 | WO2006039343A3 Emmprin antagonists and uses thereof |
| 01/04/2007 | WO2006039325A3 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/04/2007 | WO2006020598A3 Amido compounds and their use as pharmaceuticals |
| 01/04/2007 | WO2006014865A3 Compositions containing policosanol and chromium and/or chromium salts and their pharmaceutical uses |
| 01/04/2007 | WO2006010142A3 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use |
| 01/04/2007 | WO2006009805A3 Combination of a chemotherapeutic agent and an antagonist of a gene product for treating tumors |
| 01/04/2007 | WO2006004684A8 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 01/04/2007 | WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors |
| 01/04/2007 | WO2005115466A8 Combinations comprising antimuscarinic agents and corticosteroids |
| 01/04/2007 | WO2005108622A3 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration |
| 01/04/2007 | WO2005097138A3 Combinations comprising oxcarbazepine to treat affective disorders |
| 01/04/2007 | WO2005079769A3 Piperazine derivatives for the treatment of endometriosis |
| 01/04/2007 | WO2005077968B1 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 01/04/2007 | WO2005069894A8 Conformationally constrained smac mimetics and the uses thereof |
| 01/04/2007 | WO2005060979A8 Elemental sulfur as an oral or parentral medical product |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | WO2005009359A3 Agents, compositions and methods for enhancing neurological function |
| 01/04/2007 | WO2004062599A3 Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 01/04/2007 | US20070006332 Methods for enhancing embryo viability |
| 01/04/2007 | US20070005124 Endoluminal prosthesis comprising a therapeutic agent |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004904 G-csf conjugates |
| 01/04/2007 | US20070004808 Forming germicidal aromatic dialdehydes with acetals |
| 01/04/2007 | US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases |
| 01/04/2007 | US20070004806 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 01/04/2007 | US20070004805 Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| 01/04/2007 | US20070004804 Crystal structure; comminution in solvent; crystallization; antidiabetic compound |
| 01/04/2007 | US20070004803 Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase |
| 01/04/2007 | US20070004802 Method for treating renal disease |
| 01/04/2007 | US20070004801 Amidobetaines for oral care applications |
| 01/04/2007 | US20070004800 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents |
| 01/04/2007 | US20070004799 Novel compounds for the treatment of obesity |
| 01/04/2007 | US20070004798 Amminecyclohexanecarbonitriledichloroplatinum; platinum is capable of rapidly undergoing chelation with the Guanine or Adenine base of a DNA oligonucleotide at the 7 position |
| 01/04/2007 | US20070004797 Methods and dosage forms for reducing side effects of carbamate compounds |
| 01/04/2007 | US20070004796 Processes for the preparation of protected-(+)-catechin and (-)-epicatechin monomers, for coupling the protected monomers with an activated, protected epicatechin monomer, and for the preparation of epicatechin-(4B,8)-epicatechin or -catechin dimers and their digallates |
| 01/04/2007 | US20070004795 Antidepressant oral pharmaceutical compositions |
| 01/04/2007 | US20070004794 Novel salicylic anilides |
| 01/04/2007 | US20070004792 Method of treating hypertension with a very low dose of chlorthalidone |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/04/2007 | US20070004790 Nonsedating Alpha-2 Agonists |
| 01/04/2007 | US20070004789 4-(3-Hydroxymethyl-cyclohex-3-enylmethyl)-1,3-dihydro-imidzole-2-thione; side effects reduction; analgesics; chronic neuropathic and visceral pain; for reducing intraocular pressure |
| 01/04/2007 | US20070004788 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
| 01/04/2007 | US20070004787 4-Substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same |